Ticker Scorecard - AURA Basics Company: Aura Biosciences, Inc. Common Stock IPO Date: October 29, 2021 Sector: Healthcare Industry: Biotech Market Cap: $375.14M Activated in VL: True Average Daily Range Avg Daily Range: $0.40 | 3.07% Avg Daily Range (30 D): $0.13 | 1.61% Avg Daily Range (90 D): $0.20 | 2.19% Institutional Daily Volume Avg Daily Volume: .09M Avg Daily Volume (30 D): .11M Avg Daily Volume (90 D): .15M Trade Size Avg Trade Size (Sh.): 73 Avg Trade Size (Sh.) (30 D): 68 Avg Trade Size (Sh.) (90 D): 77 Institutional Trades Total Inst.Trades: 69 Avg Inst. Trade: $2.23M Avg Inst. Trade (30 D): $1.58M Avg Inst. Trade (90 D): $1.26M Avg Inst. Trade Volume: .22M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.29M Avg Closing Trade (30 D): $3.28M Avg Closing Trade (90 D): $3.28M Avg Closing Volume: 410.8K     News Oct 15, 2024 @ 4:40 PM 3 Small-Cap Stocks Ready to Deliver Significant Gr... Source: Marketbeat, Benzinga Contributor Jul 1, 2024 @ 1:17 PM UnitedHealth (UNH), Amedisys Clear Merger Hurdle W... Source: Zacks Equity Research Jun 25, 2024 @ 4:00 PM Teladoc (TDOC) Harnesses AI for Diabetes Care, Sto... Source: Zacks Equity Research Jun 11, 2024 @ 4:22 PM Brookdale (BKD) Sees 31 Months of Y/Y Occupancy Gr... Source: Zacks Equity Research Jun 6, 2024 @ 1:55 PM Wall Street Analysts See a 162.63% Upside in Aura ... Source: Zacks Equity Research Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.42 $-.41 $-.4 Diluted EPS $-.42 $-.41 $-.4 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -21.04M $ -20.34M $ -19.71M Operating Income / Loss $ -23.23M $ -22.76M $ -22.31M Cost of Revenue $ $ $ Net Cash Flow $ -4.67M $ 3.8M $ -14.8M PE Ratio